Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.

OBJECTIVES To describe the characteristics of patients with Sjögren's disease (SjD) and inclusion-body myositis (IBM), and how they compare to SjD patients with other inflammatory myopathies (IM). METHODS Patients were retrospectively recruited from 13 French centers and included if they met the ACR/EULAR criteria for SjD and for IM. They were categorized as SjD-IBM if sub-criteria for IBM were met, or as SjD-other IM if not. RESULTS SjD-IBM patients (n = 22) were mostly females (86%), with a median [Q1; Q3] age of 54 [38.5; 64] years at SjD diagnosis, and 62 [46.5; 70] years at first IBM symptoms. Although most patients displayed glandular and immunological abnormalities, additional extra-glandular manifestations were uncommon, resulting in moderate disease activity at SjD diagnosis (ESSDAI 5.5 [1; 7.8]). Classic IBM features were frequent, such as progressive symptom onset (59%), asymmetrical (27%) and distal (32%) involvements, dysphagia (41%), low CPK (386.5 [221.8; 670.5] UI/l) and CRP (3.0 [3; 8.5] mg/l) levels. Immunosuppressants were reported as efficient in 55% of cases.Compared with SjD-IBM patients, SjD patients with other IM (n = 50) were significantly younger, displayed more frequent additional extra-glandular disease, higher ESSDAI score (11 [3; 30]), shorter delay between SjD diagnosis and myositis onset (0 [-0.5; 26]), more frequent CPK values over 1000 UI/l (36%), and less frequent classic IBM features. CONCLUSION IBM can occur in SjD patients, with muscle features reminiscent of classic sporadic IBM characteristics, but mostly affecting women. In SjD patients with muscle involvement, extra-glandular manifestations, high ESSDAI score, elevated CPK values, and shorter delay after SjD diagnosis plead against IBM.

• Publication year

  2024

• Venue

  Rheumatology

• Publication date

  2024-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/keae129PMID 38430004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential common molecular mechanisms between Sjögren syndrome and inclusion body myositis: a bioinformatic analysis and in vivo validation

  2023cited by this paper
• Macroglossia in rapidly progressive inclusion body myositis

  2022cited by this paper
• Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.

  2021cited by this paper
• Sporadic inclusion body myositis and primary Sjogren’s syndrome: an overlooked diagnosis

  2021cited by this paper
• Inclusion‐body myositis and primary Sjögren syndrome: mechanisms for shared etiologies

  2020cited by this paper
• Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS.

  2020cited by this paper
• A Patient with Sjogren’s Syndrome and Subsequent Diagnosis of Inclusion Body Myositis and Light-Chain Amyloidosis

  2019cited by this paper
• Sjögren Syndrome Associated with Inflammatory Muscle Diseases

  2018cited by this paper
• 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

  2017cited by this paper
• Myositis in primary Sjögren's syndrome: data from a multicentre cohort.

  2015cited by this paper
• Inclusion body myositis associated with Sjögren’s syndrome

  2012cited by this paper
• The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.

  2011cited by this paper
• [Primary Sjögren syndrome and inclusion body myositis].

  2009cited by this paper
• [Inclusion body myositis associated with chronic thyroiditis, Sjögren's syndrome and autoimmune cholangitis].

  2004cited by this paper
• [Inclusion body myositis and primary Sjögren syndrome].

  2003cited by this paper
• Inclusion body myositis in connective tissue disorders: case report and review of the literature

  2003cited by this paper
• Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain.

  2002cited by this paper
• Primary Sjögren's syndrome associated with inclusion body myositis.

  2002cited by this paper
• Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome.

  1992cited by this paper
• Inclusion body myositis and Sjogren's syndrome.

  1985cited by this paper
• Inclusion body myositis associated with Sjögren's syndrome.

  1982cited by this paper

• The immunological mechanisms linking systemic lupus erythematosus and neuropsychiatric disorders

  2025cites this paper
• Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study

  2025cites this paper
• Case Report: Progressive interstitial lung disease secondary to Sjögren’s disease in a patient with inclusion body myositis complicated by dysphagia—a multidisciplinary approach and therapeutic challenges

  2025influential citation
• Inflammatory myopathies in 2024: Better classify them to better treat them.

  2024cites this paper
• Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

  2024cites this paper